SPOTLIGHT -
Shared insight on the current state of HER2 classification and testing and in breast cancer, with respect to how it may influence future treatment approaches.
Further Study and Tailored Treatments Remain Unmet Needs in Male Breast Cancer
Nair Notes the Benefits of Yoga as a Complementary Therapy in Nonmetastatic Breast Cancer
Accuracy of Sentinel Lymph Node Biopsies Are Vital to Inform Treatment Decisions in Breast Cancer
Goetz and Choong Describe the Need for Adjuvant Endocrine Therapy in ER-positive Breast Cancer
Novel Biomarker Tests Increase Accuracy of Breast and Lung Cancer Diagnoses
Updates From 2022 SABCS Underscore the Continued Expansion of Treatment Options in Metastatic Breast Cancer
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)